Nektar Therapeutics | Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
Agios Pharmaceuticals USD 58.28M 241K 2025-09
ALKERMES USD 165.1M 49K 2025-09
Alterity Therapeutics Limited AUD 213.97M 144.39K 2023-06
Amgen USD 539M 1000K 2025-12
Baxter International USD 683M 0 2024-12
BioCryst Pharmaceuticals USD 1.9M 3K 2023-09
Biogen USD 146.7M 200K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Cara Therapeutics USD 2K 3K 2025-03
Cipla INR 807.77M 807.43M 2025-09
Dr.Reddys Laboratories INR 832.52M 144K 2025-09
Eisai JPY 282.11M 1000 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Esperion Therapeutics USD 112K 11K 2023-09
Exelixis USD 268.1M 2.03M 2025-09
Gilead Sciences USD 1.24B 0 2025-09
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Grifols EUR 679.73M 0 2025-09
Halozyme Therapeutics USD 117.52M 98K 2025-09
Incyte USD 196.13M 2.01M 2025-09
Ionis Pharmaceuticals USD 161.14M 160.98M 2025-09
Ironwood Pharmaceuticals USD 160K 0 2024-12
Karyopharm Therapeutics USD 13K 0 2024-09
MacroGenics USD 63.26M 62.63M 2025-09
Merck USD 2.49B 15.79M 2025-09
Nektar Therapeutics USD 19K 0 2024-09
Neurocrine Biosciences USD 99.7M 700K 2025-09
Novartis USD 1.94B 23.4M 2025-06
Pfizer USD 5.69B 1000K 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Sarepta Therapeutics USD 104.77M 7.06M 2025-09
Takeda JPY 1.58B 2K 2025-12
Teva Pharmaceutical Industries USD 1.15B 0 2025-12
Xencor USD 71.34M 46K 2025-09


Nektar Therapeutics Capital Social Ordinario - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.